Top insider buys: Jan 8 – Jan 14, 2024

The largest open-market purchases company insiders reported on SEC Form 4 between Jan 8 – Jan 14, 2024.

Week 2, 2024

#CompanyWho boughtSharesValueSource
1SLDB

Solid Biosciences Inc.

2 officers/directors

Cluster buy

PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P.

4,314,873

$23.9M

SEC filings
2OPK

OPKO HEALTH, INC.

3 officers/directors

Cluster buy

Phillip Md Et Al Frost, Gary J. Nabel, Jane Ph D. Hsiao

2,377,725

$2.2M

SEC filings
3Nuveen Churchill Direct Lending Corp.

2 officers/directors

Cluster buy

James Joseph Ritchie, David M. Kirchheimer, TEACHERS INSURANCE & ANNUITY ASSOCIATION OF AMERICA

21,757

$393K

+$15.7M by large holders

SEC filings
4DYN

Dyne Therapeutics, Inc.

Director

Dirk Kersten

1,714,285

$30.0M

SEC filings
5EYPT

EyePoint Pharmaceuticals, Inc.

10% Owner

Cormorant Asset Management, LP

855,000

$17.1M

SEC filings
6LPSN

LIVEPERSON INC

10% Owner

Vector Capital Management, L.P.

1,805,569

$6.3M

SEC filings
7ECAT

BlackRock ESG Capital Allocation Term Trust

2 separate filers

Saba Capital Management, L.P., Richard M. Rieder

198,836

$3.2M

SEC filings
8NQP

NUVEEN PENNSYLVANIA QUALITY MUNICIPAL INCOME FUND

10% Owner

Saba Capital Management, L.P.

154,616

$1.8M

SEC filings
9KALV

KalVista Pharmaceuticals, Inc.

10% Owner

Venrock Healthcare Capital Partners III, L.P.

137,700

$1.7M

SEC filings
10NXJ

NUVEEN NEW JERSEY QUALITY MUNICIPAL INCOME FUND

10% Owner

Saba Capital Management, L.P.

111,421

$1.3M

SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.